Sanjiv Patel, President and CEO at Relay Therapeutics, Inc. (RLAY), sold 48,199 shares at $19.58 ($944K) on 2026-07-07, disclosed to the SEC on 2026-07-08.
Scheduled sale ($944k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RLAY | SELL | 2026-08-18 | $980K | — | Filing → |
| RLAY | SELL | 2026-01-07 | $338K | — | Filing → |
| RLAY | SELL | 2025-11-04 | $435K | — | Filing → |